Please wait

 

 

 

As filed with the Securities and Exchange Commission on February 8, 2016

Registration No. 333-                    

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM S-8

 

REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

 

EVERYDAY HEALTH, INC.

   (Exact name of registrant as specified in its charter)   

 

 

Delaware 80-0036062
(State of incorporation or organization) (I.R.S. Employer Identification No.)
   
   
345 Hudson Street, 16th Floor
New York, NY
10014
(Address of principal executive office) (Zip Code)
   
   
2014 Equity Incentive Plan
2014 Employee Stock Purchase Plan
(Full title of the plans)

 

Benjamin Wolin
Chief Executive Officer
345 Hudson Street, 16th Floor
New York, NY 10014
(646) 728-9500

(Name, address and telephone number, including area code, of agent for service)

 

Copies to:

Babak Yaghmaie
Darren DeStefano

Cooley LLP

1114 Avenue of the Americas

New York, NY 10036-7798
(212) 479-6000

Alan Shapiro
Executive Vice President
& General Counsel
Everyday Health, Inc.
345 Hudson Street, 16th Floor

New York, NY 10014

(646) 728-9500

 

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large Accelerated filer   ¨   Accelerated filer   x
             
Non-accelerated filer   ¨  (Do not check if a smaller reporting company)   Smaller reporting company   ¨

 

 
 

 

CALCULATION OF REGISTRATION FEE

Title of Securities

To Be Registered

  Amount
To Be
Registered (1)
  Proposed
Maximum
Offering Price
Per Share
  Proposed
Maximum
Aggregate
Offering Price
   Amount of
Registration Fee
 

Common Stock, $0.01 par value per share

 

                  
- Reserved for future issuance under the 2014
Equity Incentive Plan
   1,308,304(2)  $4.80(3)  $6,279,859.20   $632.39 
- Reserved for future issuance under the 2014
Employee Stock Purchase Plan
   327,076(4)  $4.80(3)  $1,569,964.80   $158.10 

TOTAL

 

   1,635,380   N/A  $7,849,824.00   $790.49 

 

(1) Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of the Registrant’s common stock that become issuable in respect of the securities identified in the above table by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without the Registrant’s receipt of consideration which results in an increase in the number of the outstanding shares of the Registrant’s common stock.

 

(2) Represents additional shares of the Registrant’s common stock reserved for issuance under the Registrant’s 2014 Equity Incentive Plan resulting from the automatic annual increase on January 1 of each year from January 1, 2015 through January 1, 2024 by the lesser of (a) 4% of the total number of shares of the Registrant’s Common Stock outstanding on December 31 of the preceding calendar year and (b) a number of shares determined by the Registrant’s board of directors.

 

(3) Estimated pursuant to Rules 457(c) and (h) of the Securities Act, solely for the purpose of calculating the registration fee, on the basis of the average of the high and low prices of the Registrant’s common stock as reported on the New York Stock Exchange on February 4, 2016.

 

(4) Represents additional shares of the Registrant’s common stock reserved for issuance under the Registrant’s 2014 Employee Stock Purchase Plan (the “ESPP”) resulting from the automatic annual increase on January 1 of each calendar year from January 1, 2015 through January 1, 2024 by the least of (a) 1% of the total number of shares of the Registrant’s Common Stock outstanding on December 31 of the preceding calendar year, (b) 400,000 shares and (c) a number shares determined by the Registrant’s board of directors that is less than (a) and (b).

 

 

 

 
 
 

 

REGISTRATION OF ADDITIONAL SHARES

PURSUANT TO GENERAL INSTRUCTION E

 

Pursuant to General Instruction E of Form S-8, Everyday Health, Inc. (the “Registrant”) is filing this Registration Statement with the Securities and Exchange Commission (the “Commission”) to register:

 

(i)1,308,304 additional shares of common stock under the Registrant’s 2014 Equity Incentive Plan, pursuant to the provisions of the 2014 Equity Incentive Plan providing for an automatic increase in the number of shares reserved and available for issuance under the 2014 Equity Incentive Plan on January 1, 2016; and

 

(ii)327,076 additional shares of common stock under the Registrant’s 2014 Employee Stock Purchase Plan, pursuant to the provisions of the Registrant’s 2014 Employee Stock Purchase Plan providing for an automatic increase in the number of shares reserved and available for issuance under the 2014 Employee Stock Purchase Plan on January 1, 2016.

 

This Registration Statement hereby incorporates by reference the contents of the Registrant’s registration statement on Form S-8 filed with the Commission on April 3, 2014 (Registration No. 333-195029). In accordance with the instructional note to Part I of Form S-8 as promulgated by the Commission, the information specified by Part I of Form S-8 has been omitted from this Registration Statement.

 

 
 

 

ITEM 8.EXHIBITS.

 

Exhibit

Number

  Description
3.1(1)   Amended and Restated Certificate of Incorporation of the Registrant.
     
3.2(2)   Amended and Restated Bylaws of the Registrant.
     
4.1(3)   Form of Common Stock Certificate of the Registrant.
     
4.2(4)   2003 Stock Option Plan, as amended, and related documents.
     
4.3(5)   2014 Equity Incentive Plan and related documents.
     
4.4(6)   2014 Employee Stock Purchase Plan.
   
5.1   Opinion of Cooley LLP.
   
23.1   Consent of Ernst & Young LLP, independent registered public accounting firm.
     
23.2   Consent of KPMG LLP, Independent Auditors of DoctorDirectory.com, Inc.
     
23.3   Consent of Tonneson & Company, PC, Independent Auditors of Cambridge BioMarketing Group, LLC.
     
23.4   Consent of R.D. McClendon CPA, P.C., Independent Auditors of Tea Leaves Health, LLC.
     
23.5   Consent of Cooley LLP. Reference is made to Exhibit 5.1.
     
24.1   Power of Attorney. Reference is made to the signature page hereto.

 

(1) Previously filed as Exhibit 3.1 to the Registrant’s Current Report on Form 8-K (File No. 001-36371), originally filed with the Commission on April 7, 2014, as amended, and incorporated herein by reference.
   
(2) Previously filed as Exhibit 3.4 to the Registrant’s Registration Statement on Form S-1 (File No. 333-194097), originally filed with the Commission on February 24, 2014, as amended, and incorporated herein by reference.
   
(3) Previously filed as Exhibit 4.1 to the Registrant’s Registration Statement on Form S-1 (File No. 333-194097), originally filed with the Commission on February 24, 2014, as amended, and incorporated herein by reference.
   
(4) Previously filed as Exhibits 10.1, 10.1.1 and 10.1.2 to the Registrant’s Registration Statement on Form S-1 (File No. 333-194097), originally filed with the Commission on February 24, 2014, as amended, and incorporated herein by reference.
   
(5) Previously filed as Exhibit 10.2 to the Registrant’s Registration Statement on Form S-1 (File No. 333-194097), originally filed with the Commission on February 24, 2014, as amended, and incorporated herein by reference.
   
(6) Previously filed as Exhibit 10.14 to the Registrant’s Registration Statement on Form S-1 (File No. 333-194097), originally filed with the Commission on February 24, 2014, as amended, and incorporated herein by reference.

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of New York, State of New York, on February 8, 2016.

 

  Everyday Health, Inc.
     
     
  By: /s/ Benjamin Wolin
    Benjamin Wolin
    Chief Executive Officer and Director

 

 
 

 

POWER OF ATTORNEY

 

KNOW ALL BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Benjamin Wolin, Brian Cooper and Alan Shapiro, and each of them, as his or her true and lawful attorneys-in-fact and agents, each with the full power of substitution, for him or her and in his or her name, place or stead, in any and all capacities, to sign any and all amendments to this Registration Statement (including post-effective amendments), and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or their or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

 

Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature

 

Title

 

Date

/s/ Benjamin Wolin  

 

Chief Executive Officer and Director

 

 

February 8, 2016

(Benjamin Wolin)   (Principal Executive Officer)    
         
/s/ Brian Cooper   Executive Vice President, Chief Financial Officer   February 8, 2016
(Brian Cooper)   (Principal Financial and Accounting Officer)    
         
  Director  

 

(Dana L. Evan)        
/s/ David Golden   Director  

 

February 8, 2016

(David Golden)        
/s/ Habib Kairouz   Director  

 

February 8, 2016

(Habib Kairouz)        
/s/ Laizer Kornwasser   Director  

 

February 8, 2016

(Laizer Kornwasser)        
/s/ Douglas McCormick   Director  

 

February 8, 2016

(Douglas McCormick)        
/s/ Myrtle Potter   Director  

 

February 8, 2016

(Myrtle Potter)        
/s/ Sharon Wienbar   Director  

 

February 8, 2016

(Sharon Wienbar)        

 

 
 

 

EXHIBIT INDEX

 

Exhibit

Number

  Description
3.1(1)   Amended and Restated Certificate of Incorporation of the Registrant.
     
3.2(2)   Amended and Restated Bylaws of the Registrant.
     
4.1(3)   Form of Common Stock Certificate of the Registrant.
     
4.2(4)   2003 Stock Option Plan, as amended, and related documents.
     
4.3(5)   2014 Equity Incentive Plan and related documents.
     
4.4(6)   2014 Employee Stock Purchase Plan.
   
5.1   Opinion of Cooley LLP.
   
23.1   Consent of Ernst & Young LLP, independent registered public accounting firm.
     
23.2   Consent of KPMG LLP, Independent Auditors of DoctorDirectory.com, Inc.
     
23.3   Consent of Tonneson & Company, PC, Independent Auditors of Cambridge BioMarketing Group, LLC.
     
23.4   Consent of R.D. McClendon CPA, P.C., Independent Auditors of Tea Leaves Health, LLC.
     
23.5   Consent of Cooley LLP. Reference is made to Exhibit 5.1.
     
24.1   Power of Attorney. Reference is made to the signature page hereto.

 

(1) Previously filed as Exhibit 3.1 to the Registrant’s Current Report on Form 8-K (File No. 001-36371), originally filed with the Commission on April 7, 2014, as amended, and incorporated herein by reference.
   
(2) Previously filed as Exhibit 3.4 to the Registrant’s Registration Statement on Form S-1 (File No. 333-194097), originally filed with the Commission on February 24, 2014, as amended, and incorporated herein by reference.
   
(3) Previously filed as Exhibit 4.1 to the Registrant’s Registration Statement on Form S-1 (File No. 333-194097), originally filed with the Commission on February 24, 2014, as amended, and incorporated herein by reference.
   
(4) Previously filed as Exhibits 10.1, 10.1.1 and 10.1.2 to the Registrant’s Registration Statement on Form S-1 (File No. 333-194097), originally filed with the Commission on February 24, 2014, as amended, and incorporated herein by reference.
   
(5) Previously filed as Exhibit 10.2 to the Registrant’s Registration Statement on Form S-1 (File No. 333-194097), originally filed with the Commission on February 24, 2014, as amended, and incorporated herein by reference.
   
(6) Previously filed as Exhibit 10.14 to the Registrant’s Registration Statement on Form S-1 (File No. 333-194097), originally filed with the Commission on February 24, 2014, as amended, and incorporated herein by reference.